Source:http://linkedlifedata.com/resource/pubmed/id/14527831
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2003-10-6
|
pubmed:abstractText |
The developing fetal and neonatal gastrointestinal (GI) tract is influenced by many growth factors, including epidermal growth factor (EGF), insulin-like growth factor (IGF), transforming growth factor (TGF), and erythropoietin (Epo). Granulocyte colony-stimulating factor (G-CSF), typically regarded as a hematopoietic growth factor, might also be included because it exists in high concentrations in amniotic fluid, colostrum, and human milk, and because granulocyte CSF receptors (G-CSF-R) are abundantly expressed on the villous enterocytes of the developing intestine. As a first step toward understanding whether the effects of G-CSF on the GI tract were local or systemic, we sought to determine whether recombinant human G-CSF (rhG-CSF) administered enterally to suckling mice, is absorbed into the circulation, and if so, whether the G-CSF-R is essential for this absorption. We enterally administered rhG-CSF to suckling mice, selecting a daily dose based on the amount of G-CSF normally swallowed by the fetus and neonate (3 ng), or in other mice, a dose of G-CSF 100 times larger (300 ng). Pups were tested at either 5-7 days of age, or at 14-16 days of age. C57BL/6 x 129SvJ mice were used. Some mice had a targeted null mutation in the G-CSF-R gene, producing a non-functional G-CSF-R protein. At intervals following the enteral G-CSF dosing, G-CSF concentrations in plasma were measured by specific ELISA. The bioavailability of G-CSF was invariably <1%, regardless of the dose of rhG-CSF given, the age of the pups, or whether they had a functional G-CSF-R. After enteral administration of rhG-CSF to suckling mice, only minimal quantities of G-CSF are absorbed into the circulation, and the G-CSF-R is not essential for this absorption.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1043-6618
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
643-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:14527831-Age Factors,
pubmed-meshheading:14527831-Animals,
pubmed-meshheading:14527831-Animals, Suckling,
pubmed-meshheading:14527831-Area Under Curve,
pubmed-meshheading:14527831-Biological Availability,
pubmed-meshheading:14527831-Enteral Nutrition,
pubmed-meshheading:14527831-Female,
pubmed-meshheading:14527831-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:14527831-Humans,
pubmed-meshheading:14527831-Male,
pubmed-meshheading:14527831-Mice,
pubmed-meshheading:14527831-Mice, Inbred C57BL,
pubmed-meshheading:14527831-Mice, Inbred Strains,
pubmed-meshheading:14527831-Mice, Knockout,
pubmed-meshheading:14527831-Receptors, Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:14527831-Recombinant Proteins
|
pubmed:year |
2003
|
pubmed:articleTitle |
Bioavailability of granulocyte colony-stimulating factor administered enterally to suckling mice.
|
pubmed:affiliation |
Department of Pediatrics, Division of Neonatology, University of Florida, Gainesville, FL 32610-0296, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|